Cargando…

It Is Time to Focus on “Segmental Remodeling” with Validated Biomarkers as “Stressed Heart Morphology” in Prevention of Heart Failure

Detalles Bibliográficos
Autores principales:	Yalcin, Fatih, Garcia, Mario J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316885/ https://www.ncbi.nlm.nih.gov/pubmed/35887943 http://dx.doi.org/10.3390/jcm11144180

Ejemplares similares

Basal Septal Hypertrophy as the Early Imaging Biomarker for Adaptive Phase of Remodeling Prior to Heart Failure
por: Yalçin, Fatih, et al.
Publicado: (2021)

Biomarkers of Myocardial Injury and Remodeling in Heart Failure
por: Ponikowska, Barbara, et al.
Publicado: (2022)

Focus on renal congestion in heart failure
por: Afsar, Baris, et al.
Publicado: (2016)

Myocardial Aspects in Aortic Stenosis and Functional Increased Afterload Conditions in Patients with Stressed Heart Morphology
por: Yalçin, Fatih, et al.
Publicado: (2021)

The AHA/ACC/HFSA 2022 Heart Failure Guidelines: Changing the Focus to Heart Failure Prevention
por: Abovich, Arielle, et al.
Publicado: (2023)

Remodeling of Cardiomyocytes: Study of Morphological Cellular Changes Preceding Symptomatic Ischemic Heart Failure
por: Kuprytė, Milda, et al.
Publicado: (2023)

Is vascular remodelling in patients with chronic heart failure exaggerated?
por: Pietschner, Robert, et al.
Publicado: (2022)

Hemodynamic stress and microscopic remodeling()
por: Yalçin, Fatih, et al.
Publicado: (2021)

Targets and management of hypertension in heart failure: focusing on the stages of heart failure
por: Miao, Huanhuan, et al.
Publicado: (2022)

Soluble ST2 biomarker and reverse remodelling in patients with systolic heart failure
por: Yalta, Kenan, et al.
Publicado: (2018)

Could early septal involvement in the remodeling process be related to the advance hypertensive heart disease?
por: Yalçin, Fatih, et al.
Publicado: (2015)

Histone deacetylase inhibition by Entinostat for the prevention of electrical and structural remodeling in heart failure
por: Freundt, Johanna K., et al.
Publicado: (2019)

Biomarkers in Heart Failure
por: Spineti, Pedro Pimenta de Mello
Publicado: (2019)

Galectin-3 in Cardiac Remodeling and Heart Failure
por: de Boer, Rudolf A., et al.
Publicado: (2010)

Atrial Electrophysiological Remodeling and Fibrillation in Heart Failure
por: Pandit, Sandeep V., et al.
Publicado: (2016)

Metabolic remodeling induced by mitokines in heart failure
por: Duan, Jiahao, et al.
Publicado: (2019)

Tracing triggers of cardiac remodelling and heart failure
por: van Driel, B. O., et al.
Publicado: (2021)

Focus on HFpEF in heart failure
por: He, Chunhui, et al.
Publicado: (2022)

Atrial remodelling in heart failure: recent developments and relevance for heart failure with preserved ejection fraction
por: Hohendanner, Felix, et al.
Publicado: (2018)

Early Protective Role of Inflammation in Cardiac Remodeling and Heart Failure: Focus on TNFα and Resident Macrophages
por: Besse, Sophie, et al.
Publicado: (2022)

Direct Thrombin Inhibitors Prevent Left Atrial Remodeling Associated With Heart Failure in Rats
por: Jumeau, Céline, et al.
Publicado: (2016)

Validity of the Seattle Heart Failure Model after heart failure hospitalization
por: Li, Song, et al.
Publicado: (2019)

Morphological and Functional Remodeling of the Ischemic Heart Correlates with Homocysteine Levels
por: Cziraki, Attila, et al.
Publicado: (2023)

Erratum to: Galectin-3 in Cardiac Remodeling and Heart Failure
por: de Boer, Rudolf A., et al.
Publicado: (2012)

Remodeling of the Purkinje Network in Congestive Heart Failure in the Rabbit
por: Logantha, Sunil Jit R.J., et al.
Publicado: (2021)

Epigenetic remodeling in heart failure with preserved ejection fraction
por: Ambrosini, Samuele, et al.
Publicado: (2022)

Monitoring of biomarkers in heart failure
por: Spoletini, Ilaria, et al.
Publicado: (2019)

Circulating MicroRNAs as Novel Potential Biomarkers for Left Ventricular Remodeling in Postinfarction Heart Failure
por: Gao, Guangyuan, et al.
Publicado: (2019)

Association between Dapagliflozin, Cardiac Biomarkers and Cardiac Remodeling in Patients with Diabetes Mellitus and Heart Failure
por: Xanthopoulos, Andrew, et al.
Publicado: (2023)

Focused Update of 2016 Korean Society of Heart Failure Guidelines for the Management of Chronic Heart Failure
por: Kim, Kyung-Jin, et al.
Publicado: (2019)

Astragalus Granule Prevents Ca(2+) Current Remodeling in Heart Failure by the Downregulation of CaMKII
por: Li, Sinai, et al.
Publicado: (2017)

Intracerebroventricular infusion of donepezil prevents cardiac remodeling and improves the prognosis of chronic heart failure rats
por: Li, Meihua, et al.
Publicado: (2020)

Primary Prevention of Heart Failure
por: Butler, Javed
Publicado: (2012)

Corrigendum to “Circulating microRNAs as Novel Potential Biomarkers for Left Ventricular Remodeling in Postinfarction Heart Failure”
por: Gao, Guangyuan, et al.
Publicado: (2022)

Sex differences in ischemic heart disease and heart failure biomarkers
por: Sobhani, Kimia, et al.
Publicado: (2018)

Novel Oxidative Stress Biomarkers with Risk Prognosis Values in Heart Failure
por: Ng, Mei Li, et al.
Publicado: (2023)

Impact of Diabetes on Postinfarction Heart Failure and Left Ventricular Remodeling
por: von Bibra, Helene, et al.
Publicado: (2011)

Antiplatelet therapy attenuates subcellular remodelling in congestive heart failure
por: Sanganalmath, Santosh K, et al.
Publicado: (2008)

Autonomic dysfunction is associated with cardiac remodelling in heart failure patients
por: Ali, Amna, et al.
Publicado: (2017)

Phosphorylation of Hsp20 Promotes Fibrotic Remodeling and Heart Failure
por: Gardner, George T., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_b4u9nb6o9sggb7qiauj0sjlaml